Illimis Therapeutics News and Activities

Acquisition, funding and merger involving Illimis Therapeutics.

• Illimis Therapeutics has just announced a $42 Million fundraising (posted on July 14 2025).

View the org chart displaying its 5 main executives

Most searched biographies at Illimis Therapeutics

• Sanghoon Park, Chief Executive Officer
• Jungu Bae, Head, Research and Development Strategy
• Junhyeok Seo, Head, Management Group

Create your alert
to follow the executive moves at Illimis Therapeutics.

Illimis Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Illimis Therapeutics

Social media about Illimis Therapeutics

• Illimis Therapeutics on Wikipedia, Google News & Yahoo Finance
• Illimis Therapeutics on LinkedIn, X (Twitter) & YouTube